0b2d4ace Aa26 439d B9d4 2ba1e16d2458 01
Methoxsalen Capsule, Liquid Filled
Product Images NDC 64380-752
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methoxsalen (NDC 64380-752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
0b2d4ace Aa26 439d B9d4 2ba1e16d2458 02
Methoxsalen is a medication available in the form of soft gelatin capsules. Each capsule contains 10mg of Methosalen USP. It is important to keep Methoxsalen out of the reach of children and to store it at a temperature between 20°-25°C, with excursions permitted between 15°C-30°C. Methoxsalen is a photoactive substance and therefore precaution must be taken to avoid exposure to sunlight and ultraviolet radiation. Dispense Methoxsalen in a light-resistant container and patients should be given a patient information leaflet. This medication is distributed by Strides Pharma Inc in East Brunswick, NJ, and is manufactured by Strides Pharma Science Ltd in Bengaluru, India. Recommended dosage is available in the accompanying NOG 64380-752-16 code.*
0b2d4ace Aa26 439d B9d4 2ba1e16d2458 03
This is a label of a medication named "Methoxsalen USP 10mg", which comes in the form of soft gelatin capsules. One capsule contains 10mg of Methoxsalen USP. It is important to keep it out of reach of children and store it in a container in controlled room temperature. The recommended dosage and the new dosage form of Methoxsalen is mentioned here with caution. The manufacturer of this medication is Strides Pharma Science Ltd, located in India, and is distributed by Strides Pharma Inc. The code number for this medication is KR/DRUBSIKTKI25/415/98 (Revised: 01/2019). There is a note for pharmacists to dispense it with patient information leaflet.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
